JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3501
Upwork
UPWK
$1.01B
| $2.53M | ﹤0.01% |
170,407
-22,123
| -11% | -$285K |
2018 Q4
20 quarters
|
|
|
IBDQ
3502
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $2.53M | ﹤0.01% |
102,323
+2,319
| +2% | +$56.8K |
2019 Q4
16 quarters
|
|
3503
IAMGOLD
IAG
$10.6B
| $2.52M | ﹤0.01% |
997,208
-1,417,905
| -59% | -$3.4M |
2021 Q4
8 quarters
|
|
3504
Dr. Reddy's Laboratories
RDY
$10.2B
| $2.52M | ﹤0.01% |
181,210
+11,085
| +7% | +$148K |
2019 Q3
17 quarters
|
|
|
CLBR.U
3505
DELISTED
Colombier Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CLBR.U
| $2.52M | ﹤0.01% |
+250,000
| New | +$2.51M |
2023 Q4
0 quarters
|
|
|
SRTA
3506
Strata Critical Medical Inc
SRTA
$418M
| $2.52M | ﹤0.01% |
713,685
+106,203
| +17% | +$305K |
2022 Q1
7 quarters
|
|
3507
Park National Corp
PRK
$3.31B
| $2.52M | ﹤0.01% |
18,931
+1,070
| +6% | +$119K |
2017 Q4
24 quarters
|
|
3508
CALL
Nice
NICE
$6.67B
| $2.51M | ﹤0.01% |
+12,600
| New | +$2.27M |
2023 Q4
0 quarters
|
|
|
HAYN
3509
DELISTED
Haynes International, Inc.
HAYN
| $2.5M | ﹤0.01% |
43,819
+6,522
| +17% | +$314K |
2016 Q3
29 quarters
|
|
3510
Danaos Corp
DAC
$3.01B
| $2.5M | ﹤0.01% |
33,725
+27,948
| +484% | +$1.9M |
2021 Q3
9 quarters
|
|
3511
Under Armour
UAA
$2.02B
| $2.5M | ﹤0.01% |
283,922
-15,682
| -5% | -$121K |
2013 Q2
42 quarters
|
|
3512
Keros Therapeutics
KROS
$225M
| $2.49M | ﹤0.01% |
62,644
+9,575
| +18% | +$300K |
2020 Q2
14 quarters
|
|
3513
Allegiant Air
ALGT
$2.12B
| $2.49M | ﹤0.01% |
30,122
-6,517
| -18% | -$471K |
2015 Q1
35 quarters
|
|
3514
CALL
PENN Entertainment
PENN
$1.98B
| $2.48M | ﹤0.01% |
+95,300
| New | +$2.21M |
2023 Q4
0 quarters
|
|
3515
VanEck Vietnam ETF
VNM
$483M
| $2.48M | ﹤0.01% |
191,736
-31,130
| -14% | -$406K |
2023 Q1
3 quarters
|
|
3516
CALL
Alaska Air
ALK
$4.41B
| $2.48M | ﹤0.01% |
63,400
| – | – |
2023 Q1
3 quarters
|
|
3517
PUT
CrowdStrike
CRWD
$277B
| $2.48M | ﹤0.01% |
38,800
+1,200
| +3% | +$62.8K |
2023 Q1
3 quarters
|
|
|
PARA
3518
PUT
DELISTED
Paramount Global Class B
PARA
| $2.47M | ﹤0.01% |
167,300
| – | – |
2022 Q1
7 quarters
|
|
|
IBTX
3519
DELISTED
Independent Bank Group, Inc.
IBTX
| $2.47M | ﹤0.01% |
48,606
+3,368
| +7% | +$137K |
2017 Q4
24 quarters
|
|
3520
Origin Bancorp
OBK
$1.65B
| $2.47M | ﹤0.01% |
69,431
-8,275
| -11% | -$262K |
2018 Q2
22 quarters
|
|
3521
Heritage Financial
HFWA
$1.15B
| $2.47M | ﹤0.01% |
115,341
+3,285
| +3% | +$59.6K |
2014 Q2
38 quarters
|
|
|
RRAC
3522
DELISTED
Rigel Resource Acquisition Corp.
RRAC
| $2.47M | ﹤0.01% |
225,000
+90,000
| +67% | +$985K |
2023 Q3
1 quarter
|
|
3523
Quanterix
QTRX
$172M
| $2.46M | ﹤0.01% |
90,073
-1
| -0% | -$24 |
2018 Q1
23 quarters
|
|
3524
Maravai LifeSciences
MRVI
$1.18B
| $2.46M | ﹤0.01% |
375,568
+55,828
| +17% | +$361K |
2020 Q4
12 quarters
|
|
3525
Coeur Mining
CDE
$18.2B
| $2.46M | ﹤0.01% |
753,076
-50,262
| -6% | -$137K |
2013 Q2
42 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.